Fusion Pharmaceuticals Announces Research Collaboration with Pepscan to Develop Peptide-Based Radiopharmaceuticals
collaboration.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.55 USD | +0.14% |
|
-.--% | +124.25% |
06-04 | Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete | MT |
06-04 | Fusion Pharmaceuticals Inc.(NasdaqGS:FUSN) dropped from NASDAQ Biotechnology Index | CI |